GlobeNewswire Inc.··DelveinsightLung Cancer Drug Race Heats Up: 100+ Companies Pursue NSCLC Breakthroughs
Over 100 pharmaceutical companies compete to develop 120+ NSCLC pipeline drugs, with 30+ in late-stage trials. Precision oncology advances drive innovation in biomarker-selected populations.
JNJMRKPFEABBVLLY+6FDA approvalclinical trials